Ashley Tompkins, CNP | |
880 Mull Ave Ste 200, Akron, OH 44313-7522 | |
(330) 590-0847 | |
Not Available |
Full Name | Ashley Tompkins |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 3 Years |
Location | 880 Mull Ave Ste 200, Akron, Ohio |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174280473 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363L00000X | Nurse Practitioner | APRN.CNP.0029895 (Ohio) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Traveling Nurse Practitioner, Llc | 7012040421 | 5 |
News Archive
Mylan Inc. today announced an expanded licensing agreement between Gilead Sciences Inc. and Mylan's Matrix Laboratories Limited.
EKF, announces that senior executives from EKF Molecular Diagnostics including CEO, Andrew Webb, will be present at the Association for Molecular Pathology.
A recently completed trial on a bee sting vaccine containing a novel adjuvant called Advax to increase its efficacy has raised hopes that severe allergic reactions, sometimes fatal, to bee venom in allergic people could soon be a thing of the past. The vaccine was designed to neutralize the venom of the European honeybee.
A detailed analysis of the epigenetics - factors controlling when and in what tissues genes are expressed - of Wilms tumor reveals striking similarities to stem cells normally found in fetal kidneys. These findings by Massachusetts General Hospital Cancer Center researchers have revealed new cellular pathways that are critical for Wilms tumor development and may also apply to other pediatric cancers.
› Verified 9 days ago
Entity Name | Traveling Nurse Practitioner, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588995849 PECOS PAC ID: 7012040421 Enrollment ID: O20100805000910 |
News Archive
Mylan Inc. today announced an expanded licensing agreement between Gilead Sciences Inc. and Mylan's Matrix Laboratories Limited.
EKF, announces that senior executives from EKF Molecular Diagnostics including CEO, Andrew Webb, will be present at the Association for Molecular Pathology.
A recently completed trial on a bee sting vaccine containing a novel adjuvant called Advax to increase its efficacy has raised hopes that severe allergic reactions, sometimes fatal, to bee venom in allergic people could soon be a thing of the past. The vaccine was designed to neutralize the venom of the European honeybee.
A detailed analysis of the epigenetics - factors controlling when and in what tissues genes are expressed - of Wilms tumor reveals striking similarities to stem cells normally found in fetal kidneys. These findings by Massachusetts General Hospital Cancer Center researchers have revealed new cellular pathways that are critical for Wilms tumor development and may also apply to other pediatric cancers.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Ashley Tompkins, CNP 880 Mull Ave Ste 200, Akron, OH 44313-7522 Ph: () - | Ashley Tompkins, CNP 880 Mull Ave Ste 200, Akron, OH 44313-7522 Ph: (330) 590-0847 |
News Archive
Mylan Inc. today announced an expanded licensing agreement between Gilead Sciences Inc. and Mylan's Matrix Laboratories Limited.
EKF, announces that senior executives from EKF Molecular Diagnostics including CEO, Andrew Webb, will be present at the Association for Molecular Pathology.
A recently completed trial on a bee sting vaccine containing a novel adjuvant called Advax to increase its efficacy has raised hopes that severe allergic reactions, sometimes fatal, to bee venom in allergic people could soon be a thing of the past. The vaccine was designed to neutralize the venom of the European honeybee.
A detailed analysis of the epigenetics - factors controlling when and in what tissues genes are expressed - of Wilms tumor reveals striking similarities to stem cells normally found in fetal kidneys. These findings by Massachusetts General Hospital Cancer Center researchers have revealed new cellular pathways that are critical for Wilms tumor development and may also apply to other pediatric cancers.
› Verified 9 days ago
Shakeilah Carelle Burns, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 S Arlington St Unit 146, Akron, OH 44306 Phone: 330-355-7055 | |
Felicia Zabala, APRN. CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-5995 | |
Mrs. Molly A. Hockin, MSN, APRN, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 340 S Broadway St, Akron, OH 44308 Phone: 330-253-3100 | |
Sarah Elizabeth Bailey, CNP-APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 444 W Exchange St, Akron, OH 44302 Phone: 330-535-2671 | |
Heather Larson, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-6060 Fax: 330-543-6069 | |
Mrs. Erika Lynn Gross, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 224 W Exchange St, Suite 160, Akron, OH 44302 Phone: 330-344-6505 | |
Lisa Young, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 |